Skip to content

Net Income at other companies

HRO
HarrowHROW
-$27.6M-55.2%
Zevra Therapeutics, Inc. logo
Zevra Therapeutics, Inc.ZVRA
$37.89M+1,323%
XER
Xeris Biopharma Holdings, Inc.XERS
$2.23M+124%
Ultragenyx Pharmaceutical logo
Ultragenyx PharmaceuticalRARE
-$185M-22.5%
ANI Pharmaceuticals logo
ANI PharmaceuticalsANIP
$29.49M+88.1%
Crinetics Pharmaceuticals logo
Crinetics PharmaceuticalsCRNX
-$127.85M-32.1%

Other financials

Income statement

See full
Revenue$24.3M+40.4%
Gross profit$14.7M+49.4%
Operating income$2.4M+614%
EPS (diluted)$0.05+183%

Balance sheet

See full
Cash & equivalents$19.7M+12.9%
Total debt$31.3M+3.7%
Total equity$30.6M+25.2%
Total assets$97.7M+16.3%

Cash flow

See full
Operating cash flow$7.4M+254%
CapEx$75.0K
Free cash flow$7.3M+251%

Valuation

See full
Market cap$930.79M+156%
Enterprise value$942.39M+150%
P/S10.7×+3.2×

Profitability

See full
Gross margin54.8%-3.7pp
Operating margin-15.1%
Net margin-9.5%-2.7pp
FCF margin17.1%

Returns & leverage

See full
Return on equity-34.2%+0.9pp
Debt / equity-0.2×
Current ratio1.2×-0.8×

Where this comes from

Reported directly by Eton Pharmaceuticals, Inc. in its filing.

Tagged under the XBRL concept us-gaap:NetIncomeLoss.

The official record: Eton Pharmaceuticals, Inc.’s 10-Q, filed May 14, 2026, on SEC EDGAR. View the filing →

Ask your AI about Eton Pharmaceuticals, Inc.'s net income.

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI
Harbor at dusk
Claude

Questions, answered.

What is Eton Pharmaceuticals, Inc.'s net income?
Eton Pharmaceuticals, Inc. (ETON) reported net income of $1.55M in Q1 2026.
How has Eton Pharmaceuticals, Inc.'s net income changed year-over-year?
Eton Pharmaceuticals, Inc.'s net income increased by 198.9% year-over-year, from -$1.57M to $1.55M.
What does net income mean?
The bottom line — total revenue minus all expenses, taxes, and costs. Represents the profit attributable to the company's shareholders after all obligations are met.